Amanda Kennedy

Amanda Kennedy has extensive experience in regulatory affairs within the pharmaceutical and biotechnology industries. Currently serving as the Director of Regulatory Affairs at Rhythm Pharmaceuticals Inc. since May 2021, Amanda previously held roles at Ultragenyx Pharmaceutical Inc. where responsibilities included managing regulatory submissions and infrastructure development. With previous positions at Replimune, Amgen, and BioVex, Amanda has demonstrated proficiency in global regulatory submissions, compliance, and the management of clinical trial documentation. Amanda holds a Certificate in Pharmaceuticals & Device from RAPS University Online and a Bachelor of Arts in English Literature from McGill University.